Cargando…
Design and Synthesis of “Chloropicolinate Amides and Urea Derivatives” as Novel Inhibitors for Mycobacterium tuberculosis
[Image: see text] A series of 30 novel diamino phenyl chloropicolinate fettered carboxamides, urea, and thiourea derivatives were synthesized by coupling of methyl 4-amino-6-(2-aminophenyl)-3-chloropyridine-2-carboxylate with different acid chlorides, urea, and thiourea moieties, respectively. All o...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818581/ https://www.ncbi.nlm.nih.gov/pubmed/33490825 http://dx.doi.org/10.1021/acsomega.0c05690 |
_version_ | 1783638864615702528 |
---|---|
author | Konduri, Srihari Bhargavi, Dodda Prashanth, Jyothi Krishna, Vagolu Siva Sriram, Dharmarajan Rao, Koya Prabhakara |
author_facet | Konduri, Srihari Bhargavi, Dodda Prashanth, Jyothi Krishna, Vagolu Siva Sriram, Dharmarajan Rao, Koya Prabhakara |
author_sort | Konduri, Srihari |
collection | PubMed |
description | [Image: see text] A series of 30 novel diamino phenyl chloropicolinate fettered carboxamides, urea, and thiourea derivatives were synthesized by coupling of methyl 4-amino-6-(2-aminophenyl)-3-chloropyridine-2-carboxylate with different acid chlorides, urea, and thiourea moieties, respectively. All of these compounds were characterized by (1)H and (13)C nuclear magnetic resonance spectroscopy, CHN analysis, and high-resolution mass spectra for confirmation of the structures. Two compounds were also characterized by single-crystal X-ray diffraction analysis to confirm the structures obtained by spectral analysis. All these 30 compounds were tested for their in vitro antimycobacterial activity using the microplate alamar blue assay method against Mycobacterium tuberculosis. Five compounds have shown good minimum inhibitory concentration (MIC) values with low cytotoxicity when compared with the reference drugs. Moreover, some of the compounds have high MIC values compared with isoniazid, rifampicin, and so forth and also had shown good reign in the spread of bacteria by the nutrient starvation model. These antimycobacterial activity results have shown a good correlation with molecular docking model analysis with the inhibitors MurB by exhibiting strong interactions. Some of these compounds could be promising candidates against M. tuberculosis for future preclinical agent drug development. |
format | Online Article Text |
id | pubmed-7818581 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-78185812021-01-22 Design and Synthesis of “Chloropicolinate Amides and Urea Derivatives” as Novel Inhibitors for Mycobacterium tuberculosis Konduri, Srihari Bhargavi, Dodda Prashanth, Jyothi Krishna, Vagolu Siva Sriram, Dharmarajan Rao, Koya Prabhakara ACS Omega [Image: see text] A series of 30 novel diamino phenyl chloropicolinate fettered carboxamides, urea, and thiourea derivatives were synthesized by coupling of methyl 4-amino-6-(2-aminophenyl)-3-chloropyridine-2-carboxylate with different acid chlorides, urea, and thiourea moieties, respectively. All of these compounds were characterized by (1)H and (13)C nuclear magnetic resonance spectroscopy, CHN analysis, and high-resolution mass spectra for confirmation of the structures. Two compounds were also characterized by single-crystal X-ray diffraction analysis to confirm the structures obtained by spectral analysis. All these 30 compounds were tested for their in vitro antimycobacterial activity using the microplate alamar blue assay method against Mycobacterium tuberculosis. Five compounds have shown good minimum inhibitory concentration (MIC) values with low cytotoxicity when compared with the reference drugs. Moreover, some of the compounds have high MIC values compared with isoniazid, rifampicin, and so forth and also had shown good reign in the spread of bacteria by the nutrient starvation model. These antimycobacterial activity results have shown a good correlation with molecular docking model analysis with the inhibitors MurB by exhibiting strong interactions. Some of these compounds could be promising candidates against M. tuberculosis for future preclinical agent drug development. American Chemical Society 2021-01-07 /pmc/articles/PMC7818581/ /pubmed/33490825 http://dx.doi.org/10.1021/acsomega.0c05690 Text en © 2021 The Authors. Published by American Chemical Society This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License (http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html) , which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes. |
spellingShingle | Konduri, Srihari Bhargavi, Dodda Prashanth, Jyothi Krishna, Vagolu Siva Sriram, Dharmarajan Rao, Koya Prabhakara Design and Synthesis of “Chloropicolinate Amides and Urea Derivatives” as Novel Inhibitors for Mycobacterium tuberculosis |
title | Design and Synthesis of “Chloropicolinate Amides
and Urea Derivatives” as Novel Inhibitors for Mycobacterium
tuberculosis |
title_full | Design and Synthesis of “Chloropicolinate Amides
and Urea Derivatives” as Novel Inhibitors for Mycobacterium
tuberculosis |
title_fullStr | Design and Synthesis of “Chloropicolinate Amides
and Urea Derivatives” as Novel Inhibitors for Mycobacterium
tuberculosis |
title_full_unstemmed | Design and Synthesis of “Chloropicolinate Amides
and Urea Derivatives” as Novel Inhibitors for Mycobacterium
tuberculosis |
title_short | Design and Synthesis of “Chloropicolinate Amides
and Urea Derivatives” as Novel Inhibitors for Mycobacterium
tuberculosis |
title_sort | design and synthesis of “chloropicolinate amides
and urea derivatives” as novel inhibitors for mycobacterium
tuberculosis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818581/ https://www.ncbi.nlm.nih.gov/pubmed/33490825 http://dx.doi.org/10.1021/acsomega.0c05690 |
work_keys_str_mv | AT kondurisrihari designandsynthesisofchloropicolinateamidesandureaderivativesasnovelinhibitorsformycobacteriumtuberculosis AT bhargavidodda designandsynthesisofchloropicolinateamidesandureaderivativesasnovelinhibitorsformycobacteriumtuberculosis AT prashanthjyothi designandsynthesisofchloropicolinateamidesandureaderivativesasnovelinhibitorsformycobacteriumtuberculosis AT krishnavagolusiva designandsynthesisofchloropicolinateamidesandureaderivativesasnovelinhibitorsformycobacteriumtuberculosis AT sriramdharmarajan designandsynthesisofchloropicolinateamidesandureaderivativesasnovelinhibitorsformycobacteriumtuberculosis AT raokoyaprabhakara designandsynthesisofchloropicolinateamidesandureaderivativesasnovelinhibitorsformycobacteriumtuberculosis |